NFG
VRTX icon

Nations Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Nations Financial Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2M Buy
4,490
+202
+5% +$94.2K 0.1% 218
2025
Q4 		$1.94M Sell
4,288
-2
-0% -$862 0.1% 212
2025
Q3 		$1.68M Buy
4,290
+74
+2% +$30.9K 0.1% 222
2025
Q2 		$1.88M Buy
4,216
+174
+4% +$80.2K 0.13% 188
2025
Q1 		$1.96M Buy
4,042
+74
+2% +$34.5K 0.15% 166
2024
Q4 		$1.6M Sell
3,968
-13
-0.3% -$6.03K 0.12% 202
2024
Q3 		$1.85M Buy
3,981
+226
+6% +$109K 0.13% 177
2024
Q2 		$1.76M Sell
3,755
-33
-0.9% -$14.3K 0.14% 165
2024
Q1 		$1.58M Buy
3,788
+468
+14% +$198K 0.13% 178
2023
Q4 		$1.35M Buy
3,320
+45
+1% +$16.6K 0.13% 191
2023
Q3 		$1.14M Buy
3,275
+145
+5% +$50.7K 0.11% 211
2023
Q2 		$1.1M Buy
3,130
+16
+0.5% +$5.39K 0.11% 221
2023
Q1 		$981K Buy
3,114
+87
+3% +$26.1K 0.1% 231
2022
Q4 		$874K Sell
3,027
-155
-5% -$47.2K 0.1% 242
2022
Q3 		$921K Sell
3,182
-744
-19% -$214K 0.13% 187
2022
Q2 		$1.11M Buy
3,926
+113
+3% +$30.2K 0.15% 170
2022
Q1 		$995K Buy
3,813
+1,365
+56% +$324K 0.12% 193
2021
Q4 		$538K Buy
+2,448
New +$476K 0.07% 283
2020
Q4 		– Sell
-1,526
Closed -$415K – 319
2020
Q3 		$415K Buy
+1,526
New +$421K 0.13% 194

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Nations Financial Group's VRTX Position: Q1 2026 in Review

Nations Financial Group increased its Vertex Pharmaceuticals (VRTX) stake by 4.7% in Q1 2026, buying an estimated $94.2K and bringing the position to 4,490 shares worth $2M. The position accounts for 0.1% of the portfolio, ranked #218.

Nations Financial Group first reported a position in VRTX in Q3 2020 and has held it in 19 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Nations Financial Group held 4,490 shares of Vertex Pharmaceuticals worth $2M as of Q1 2026.
  • Nations Financial Group bought 202 Vertex Pharmaceuticals shares in Q1 2026, an estimated $94.2K.
  • Vertex Pharmaceuticals made up 0.1% of Nations Financial Group's portfolio in Q1 2026, its #218 holding.
  • Nations Financial Group first reported a position in Vertex Pharmaceuticals in Q3 2020 and has held it in 19 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Nations Financial Group's 13F filing for Q1 2026, filed 15 Apr 2026.